CommercialBilling CodesMedium impact
07.13.05m, Photodynamic Therapy (PDT) Using Verteporfin (Visudyne®)
Independence Blue Cross·Ophthalmology, Dermatology, Oncology·Pharmacy
Effective date
Nov 17, 2025
We identified it
Jun 19, 2026
Summary
Commercial insurance policy 07.13.05m for Photodynamic Therapy (PDT) Using Verteporfin (Visudyne®) has been updated with changes to medical coding, general description, guidelines, or informational content. This is a fresh policy update that affects pharmacy-related billing for PDT procedures.
Action Required
By November 17, 2025: Billing team must review updated policy 07.13.05m for Photodynamic Therapy using Verteporfin to understand changes to coding guidelines and informational updates. Access the full policy details at the source URL to identify specific billing requirement changes and update billing procedures accordingly.